Your browser is no longer supported. Please, upgrade your browser.
CNTG Centogene N.V. monthly Stock Chart
Centogene N.V.
Index- P/E- EPS (ttm)-1.70 Insider Own36.18% Shs Outstand19.86M Perf Week5.34%
Market Cap255.27M Forward P/E- EPS next Y-1.49 Insider Trans0.00% Shs Float8.35M Perf Month4.78%
Income-33.80M PEG- EPS next Q-0.28 Inst Own50.70% Short Float2.85% Perf Quarter2.33%
Sales58.00M P/S4.40 EPS this Y-83.90% Inst Trans16.87% Short Ratio1.71 Perf Half Y-25.95%
Book/sh2.49 P/B4.76 EPS next Y17.70% ROA-27.90% Target Price- Perf Year-6.14%
Cash/sh0.96 P/C12.33 EPS next 5Y- ROE-68.50% 52W Range7.80 - 28.71 Perf YTD17.58%
Dividend- P/FCF- EPS past 5Y- ROI-21.70% 52W High-58.76% Beta-
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin44.60% 52W Low51.79% ATR0.84
Employees442 Current Ratio1.50 Sales Q/Q-13.40% Oper. Margin-53.50% RSI (14)56.28 Volatility5.72% 7.14%
OptionableNo Debt/Eq0.66 EPS Q/Q-64.90% Profit Margin-58.30% Rel Volume0.28 Prev Close11.68
ShortableYes LT Debt/Eq0.47 EarningsSep 23 BMO Payout- Avg Volume138.98K Price11.84
Recom1.20 SMA202.19% SMA507.10% SMA200-20.06% Volume38,799 Change1.37%
Apr-24-20Downgrade Evercore ISI Outperform → In-line $21
Dec-03-19Initiated Robert W. Baird Outperform
Dec-02-19Initiated Evercore ISI Outperform
Dec-02-19Initiated BTIG Research Buy
Nov-25-20 06:30AM  
Nov-13-20 11:30AM  
Nov-09-20 04:00AM  
Nov-05-20 02:00AM  
Oct-20-20 08:17AM  
Oct-19-20 06:30AM  
Oct-14-20 08:14AM  
Sep-28-20 06:30AM  
Sep-25-20 06:32AM  
Sep-23-20 08:05AM  
Sep-16-20 08:30AM  
Sep-10-20 08:15AM  
Sep-03-20 06:30AM  
Sep-01-20 08:30AM  
Aug-20-20 01:30AM  
Aug-19-20 02:00AM  
Aug-11-20 06:30AM  
Aug-04-20 06:30AM  
Jul-27-20 08:00AM  
Jul-23-20 02:30AM  
Jul-09-20 07:19PM  
Jul-07-20 06:16PM  
Jul-06-20 06:30AM  
Jul-02-20 08:03AM  
Jul-01-20 10:22AM  
Jun-29-20 03:12PM  
Jun-28-20 09:41PM  
Jun-23-20 06:30AM  
Jun-15-20 06:30AM  
Jun-08-20 06:30AM  
Jun-04-20 11:00PM  
May-15-20 06:30AM  
May-12-20 01:16PM  
May-08-20 02:00PM  
May-06-20 06:30AM  
May-05-20 09:30AM  
Apr-23-20 06:30AM  
Apr-21-20 11:00AM  
Apr-17-20 06:30AM  
Apr-16-20 11:24AM  
Apr-15-20 09:29AM  
Mar-18-20 02:13PM  
Mar-17-20 03:39PM  
Mar-09-20 10:05AM  
Feb-29-20 12:00AM  
Feb-25-20 06:30AM  
Feb-12-20 06:30AM  
Dec-16-19 06:37AM  
Dec-06-19 06:00AM  
Dec-05-19 06:28AM  
Dec-03-19 03:29PM  
Dec-02-19 03:00AM  
Nov-21-19 08:54AM  
Nov-18-19 08:00AM  
Nov-07-19 03:12AM  
Centogene N.V., together with its subsidiaries, engages in diagnosis and research around rare diseases that transform clinical and genetic data into information for patients, physicians, and pharmaceutical companies. Its platform analyzes epidemiologic, phenotypic, and genetic data to enhance the understanding of rare hereditary diseases. The company operates through two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Diagnostics segment provides genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.